Skip to content

Clinical application of Fistula Laser Closure (FiLaC) in perianal fistula of Crohn's disease

Clinical application of Fistula Laser Closure (FiLaC) in perianal fistula of Crohn's disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041582
Enrollment
Unknown
Registered
2020-12-31
Start date
2018-10-01
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perianal fistula of Crohn's disease

Interventions

treatment group:Fistula Laser Closure
control group:Loose wire drainage

Sponsors

Baoshan Branch of Renji Hospital Affiliated to Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of perianal Crohn's disease in Renji Hospital or Baoshan Branch Renji was consistent with the above-mentioned diagnosis of perianal Crohn's disease. Perianal magnetic resonance imaging confirmed anal fistula, and the fistula was in stable stage. Patients who have not received any specialized equipment or surgical treatment in the past 3 months. 2. The age was 16 to 65 years old, and the lower age limit was set at 16 years old because Crohn's disease was prevalent in adolescents. 3. The subjects had no major organ dysfunction, normal blood routine, liver, kidney and heart function. 4. obtain the informed consent of the patients.

Exclusion criteria

Exclusion criteria: 1. Patients with colorectal tumors, lymphomas and other diseases; have a history of malignant tumors. 2. Patients with severe underlying diseases, heart, lung, kidney and other serious diseases. 3. The patients with severe mental illness or poor compliance could not cooperate with the research program. 4. Patients with active infections such as viral hepatitis, tuberculosis and intestinal infectious diseases. 5. Female patients during lactation and pregnancy.

Design outcomes

Primary

MeasureTime frame
Cure rate;

Secondary

MeasureTime frame
Duration of surgery;hemorrhage during surgery;visual analogue scale;Laser therapy energy and time;ASA score;

Countries

China

Contacts

Public ContactCui Zhe

Baoshan Branch of Renji Hospital Affiliated to Shanghai Jiaotong University

drcui1568@163.com+86 13512177595

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026